Louvain Drug Research Institute

The general objective of the Louvain Drug Research Institute (LDRI) is to develop fundamental and/or applied research projects in the field of drugs.

The research axes encompass the discovery and the conception of new active molecules, the study of their pharmacological profile, their metabolism and toxicity, their formulation, and the optimization of their use. These research projects are supported by two technological platforms: mass spectrometry analyses and pre-clinical magnetic resonance.

 

President : Marie-Paule Mingeot
Vice-Presidents : Véronique Préat, Bernard Gallez

latest news Fil RSS
 
> The Université catholique de Louvain is looking for a full-time specialist in Clinical Pharmacy
The successful candidate will carry out research at the Louvain Drug Research Institute in the field of evaluation of the quality of medication use in clinical practice. The research will be oriented towards pharmacoepidemiology and/or evaluative research (including clinical pharmacy).
[5/10/2011 > more]
 
 
| 3/10/2011 |
LDRI SEMINARS
 
> Dr A. Neyrinck, Metabolism and Nutrition Research Group
Cibler le microbiote intestinal dans la gestion de l'obésité: intérêt des arabinoxylo(oligo) saccharides de blé
February, 20 - Salle Couvreur - 13.00
[ > more]
 
 
DOCTORAL SCHOOL SEMINARS
 
> Lionel Mignion (Biomedial Magnetic Resonance)
La choline comme cible thérapeutique et comme marqueur de réponse dans des modèles tumoraux : étude par spectroscopie par résonance magnétique (MRS) et par micro-Tomographie par Emission de Positrons (TEP)
February, 13 - Salle Couvreur - 13.00
[ > more]
 
 
 
> Ly Binh An Tran (Biomedical Magnetic Resonance)
Bridging the gap between tumor hypoxia and tumor response: Access the value of imaging biomarkers and the effect of dose escalation
February, 13 - Salle Couvreur - 13.00
[ > more]